OpenAlex
PricingAboutJobs
Log inGet started
Work

Provider- and facility-level factors in relation to patients’ receipt of chemotherapy, time to chemotherapy initiation, and receipt of guideline regimens: Results from the optimal breast cancer chemotherapy dosing study.

HTML

Year: 2023
Type: conference-abstract
Source: JCO Oncology Practice
DOI: 10.1200/op.2023.19.11_suppl.540
Authors: Elizabeth Kantor, Kelli O'Connell, Jenna Bhimani, Isaac J. Ergas, Narre Heon, Grace B Gallagher, Jennifer J. Griggs, Tatjana Kolevska, Yuriy Kotsurovskyy, Candyce Kroenke, Cecile Laurent, Raymond Liu, Sonia Persaud, Donna Rivera, Janise M. Roh, Sara Tabatabai, Emily Valice, Elisa Victoria Bandera, Erin Aiello Bowles, Lawrence H. Kushi
Institutions: Memorial Sloan Kettering Cancer Center, Kaiser Permanente, Kaiser Permanente Northern California, University of Michigan, Kaiser Permanente San Francisco Medical Center, National Cancer Institute, Rutgers Cancer Institute, Kaiser Permanente Washington Health Research Institute
Language: English

Topic: Breast Cancer Treatment Studies
Subfield: Cancer Research
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
SDGs: Good health and well-being, Reduced inequalities

Open Access status: closed

Funder: National Institutes of Health
OpenAlex ID: W4388201479
Cites:
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms